Market Research Logo

Conference Documentation: 3rd Annual Pre-Filled Syringes East Coast

Conference Documentation: 3rd Annual Pre-Filled Syringes East Coast

SMi Group’s 3rd annual Pre-Filled Syringes East Coast conference returns to the New Jersey in April 2016.

With exponential growth of biologics and protein-based products, demand for pre-filled syringes (PFS) is growing on an exponential scale. As such, the global pre-filled syringes (PFS) market is presenting lucrative opportunities for both pharma and device companies- the investment forecast expects to exceed $6.6.bn by 2020. According to a recent study led by Brigham and Women's Hospital (BWH) in Boston*, switching to PFS can also cut related costs by almost 50%, equivalent to $162,000 in savings!

While we have witnessed booming investments in PFS, pharma and device manufacturers still need to overcome a number of challenges to commercialize PFS. It also faces fierce competition with innovative drug delivery platforms. Hence, developing a drug-compatible and patient-centric PFS remain top priority amongst market participant.

Emulating on previous success, the 3rd Annual Pre-Filled Syringes East Coast will delve further into the core issues of PFS including
human factor engineering
PFS material selection and GMP compliance
compatibility and injectability considerations for complex biologics and combination product

and many more!


Conference Documentation: 3rd Annual Pre-Filled Syringes East Coast

SMi Group’s 3rd annual Pre-Filled Syringes East Coast conference returns to the New Jersey in April 2016.

With exponential growth of biologics and protein-based products, demand for pre-filled syringes (PFS) is growing on an exponential scale. As such, the global pre-filled syringes (PFS) market is presenting lucrative opportunities for both pharma and device companies- the investment forecast expects to exceed $6.6.bn by 2020. According to a recent study led by Brigham and Women's Hospital (BWH) in Boston*, switching to PFS can also cut related costs by almost 50%, equivalent to $162,000 in savings!

While we have witnessed booming investments in PFS, pharma and device manufacturers still need to overcome a number of challenges to commercialize PFS. It also faces fierce competition with innovative drug delivery platforms. Hence, developing a drug-compatible and patient-centric PFS remain top priority amongst market participant.

Emulating on previous success, the 3rd Annual Pre-Filled Syringes East Coast will delve further into the core issues of PFS including
human factor engineering
PFS material selection and GMP compliance
compatibility and injectability considerations for complex biologics and combination product

and many more!

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report